Treprostinil
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Rajan Saggar
Overview
Treprostinil is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Treprostinil clinical trials
Explore related
Medical disclaimer. This page summarizes research about Treprostinil for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.